Calprotectin and sarcopenia in COPD: biomarker, bystander or target?Šarc, Irena (Avtor) Langen, Ramon C. J. (Avtor) Gosker, Harry Reinier (Avtor) Lainščak, Mitja (Avtor) calprotectinmuscle atrophyS100A9 pathway inhibition20262026-05-21 10:05:04Članek v reviji182710UDK: 616.24-007.272:616.74-007.23ISSN pri članku: 2190-6009DOI: 10.1002/jcsm.70283COBISS_ID: 274203395sl